U.S. Consumer Durables Stock News

If you are wondering whether TG Therapeutics is still a smart bet at around $30 a share, you are not alone. This stock sits right in the crosshairs of growth hopes and valuation worries. Despite being down 8.3% over the last week, 9.1% over the past month, and 9.6% over the last year, the stock is still up 268.6% over three years, a pattern that often signals shifting risk perceptions rather than a simple boom-or-bust story. Recent headlines have focused on the company’s progress in...

If you have been wondering whether First Commonwealth Financial is quietly trading at a bargain or already priced for perfection, you are not alone. The stock closed at $16.50 recently, with returns of 7.9% over the last month but still down 8.8% over the past year, a pattern that hints at shifting views on its growth prospects and risk profile. Recent headlines around regional banks have focused on balance sheet resilience, deposit stability, and how smaller lenders are navigating a higher...

Wondering if Verisk Analytics is finally trading at a price that makes sense, or if the recent share moves are just noise in a data heavy story? The stock has inched up about 0.4% over the last week and 4.4% in the last month, but that comes after a tough stretch with shares still down 17.8% year to date and 22.4% over the past year, even though the three year and five year returns remain positive at 25.2% and 19.9% respectively. Recently, investors have been digesting updates around...

If you are wondering whether Consolidated Edison still looks sensible at today's price, or if the steady dividend giant is quietly getting expensive, you are in the right place to break down what the numbers really say. The stock has eased slightly in the short term, slipping about 2.0% over the last week and 0.6% over the last month, but it is still up 8.8% year to date and roughly 55.4% over five years. That pattern points to a sturdier long term story than recent noise suggests. Recent...

Wondering if ONE Gas is still good value after its latest run higher, or whether the easy money has already been made? This breakdown is designed to help you decide if the current price really makes sense. The stock is up 18.0% year to date and 11.6% over the past year, even after a recent 3.3% pullback in the last week and a modest 1.0% dip over the past month, which suggests investors are still broadly optimistic but increasingly selective on price. Recent attention around regulated...

If you are wondering whether Johnson Controls International is still worth buying after such a big run up, you are not alone. This is exactly what we are going to unpack today. The stock has been grinding higher, up about 0.5% over the last week, 0.8% over the past month, 46.0% year to date, and 42.1% over the last year. These gains build on multi-year returns of 85.8% over three years and 182.9% over five years. Recently, investors have been reacting to a steady drumbeat of news around...

Boyd Gaming (BYD) has been quietly grinding higher this year, and with the stock up about 14% year to date investors are starting to reassess what they are actually paying for. See our latest analysis for Boyd Gaming. The recent 1 month share price return of 4.87 percent, on top of a 13.69 percent year to date share price gain, suggests steady momentum. A 5 year total shareholder return of 100.36 percent shows the longer term story has been rewarding for patient investors even as short term...

United Natural Foods (UNFI) opened fiscal Q1 2026 with revenue of about $7.8 billion and a basic EPS loss of roughly $0.07, alongside a trailing 12 month EPS of around negative $1.67 and net income of negative $101 million, keeping the bottom line in the red despite steady sales. The company has seen quarterly revenue move from $7.9 billion in Q1 2025 to $7.8 billion in Q1 2026, while basic EPS losses narrowed from about $0.35 a year ago and sat against a trailing 12 month revenue base of...

If you are wondering whether Stoke Therapeutics is still worth buying after its huge run, you are not alone. This article is going to unpack what the current price is really implying about the company. The stock has pulled back about 4.5% over the last week, but is still up roughly 14.2% over the past month and an eye catching 164.5% year to date, with a 132.7% gain over the last year and 321.6% over three years, despite being down 40.7% over five years. Those swings are not happening in a...

Kura Oncology recently reported that it completed the first U.S. commercial sale of KOMZIFTI (ziftomenib), its newly FDA-approved oral menin inhibitor for adults with relapsed or refractory NPM1‑mutated acute myeloid leukemia, which also triggered a US$135,000,000 milestone payment from partner Kyowa Kirin expected before year-end 2025. This first sale, combined with KOMZIFTI’s inclusion in NCCN guidelines as a Category 2A recommended option, signals early clinical acceptance and provides an...

If you have been wondering whether Cadence Design Systems at around $317 a share is still worth buying, you are not alone. This article is going to walk through what the current price really implies. The stock is up 3.8% over the last week, down 5.2% over the past month, modestly ahead 6.8% year to date, but down 2.0% over the last year after a 98.0% 3 year and 175.3% 5 year run. Those mixed returns come as investors digest a steadier phase for semiconductor and AI related spending, with...

MongoDB (MDB) has just posted its Q3 2026 numbers, with revenue of about $628.3 million and basic EPS of roughly -$0.02, alongside net income excluding extra items of approximately -$2.0 million, marking another quarter where growth and profitability are still in tension. The company has seen quarterly revenue move from around $478.1 million in Q2 2025 to $628.3 million in Q3 2026. Basic EPS has swung between about -$0.74 and a brief positive patch of roughly $0.20 before landing at -$0.02...

NIP Group (NIPG) has kicked off H1 2025 with total revenue of about $45.9 million and basic EPS of roughly -$0.16, setting a cautious tone as the market digests another loss-making half. The company has seen revenue hover in the mid-$40 million range over recent periods, from about $45.1 million in H2 2023 to $39.3 million in H1 2024 and back to $45.9 million in H2 2024. Basic EPS stayed negative across the board, ranging from roughly -$1.64 to -$2.09 before the latest -$0.16 print. With the...

Wondering if Amkor Technology is still a smart buy after its big run, or if the easy money has already been made? This breakdown will help you decide whether the current price still makes valuation sense. The stock has been on a tear lately, jumping 16.4% in the last week, 7.4% over the past month, and racking up a 56.3% gain year to date, on top of strong multi-year returns of 55.3% over 1 year, 62.6% over 3 years, and 194.5% over 5 years. Behind those moves, investors have been focusing on...

Zebra Technologies has announced that Melissa Luff Loizides will become Chief People Officer on January 1, 2026, succeeding Jeff Schmitz, who will oversee the Elo acquisition integration through the second quarter of 2026 before retiring. This planned succession highlights Zebra’s emphasis on continuity in talent leadership at the same time it works to integrate Elo and support long-term workforce planning. Next, we’ll examine how this leadership transition in the People function may...

If you are wondering whether Cboe Global Markets is still worth buying after its big run, or if you are late to the party, this breakdown will help you decide whether the current price still makes sense. The stock is down 1.2% over the last week but up 3.5% over the past month. Its 29.5% year to date gain, 21.3% 1 year return, and substantial 105.8% and 198.6% returns over 3 and 5 years indicate that the market has been steadily re rating the business. Recently, investors have been focused...

If you are looking at Vornado Realty Trust and wondering whether this beaten up New York office landlord is quietly turning into a value opportunity, you are not alone. The stock closed at $36.49 and is down 0.9% over the last week, 3.3% over the past month, and 14.4% year to date, but it is still up a hefty 79.1% over three years and 8.3% over five years, a reminder of how quickly sentiment around this name can swing. Those mixed returns sit against a backdrop of ongoing uncertainty around...

ESCO Technologies (ESE) just wrapped up FY 2025 with fourth quarter revenue of about $352.7 million and basic EPS of roughly $1.73, capping off a twelve month run that delivered around $1.10 billion in revenue and EPS of about $4.51. Over the past year, the company has seen quarterly revenue move from roughly $273.5 million in Q4 2024 to $352.7 million in Q4 2025, while basic EPS shifted from about $1.52 to $1.73. This leaves investors focused closely on how its margins are holding up as...

Wondering if Republic Services at around $212 a share is still worth buying after that long run up, or if most of the upside is already priced in, you are not alone. The stock has slipped about 2.0% over the last week but is still up 2.1% over the past month, 6.3% year to date and 140.1% over five years. That naturally raises questions about how much future growth is already embedded in the price. Recent moves have come against a backdrop of steady contract wins, long term municipal...

Simulations Plus (SLP) just closed FY 2025 with fourth quarter revenue of about $17.5 million and basic EPS of roughly -$0.03, capping a volatile year in which quarterly revenue swung between $17.5 million and $22.4 million while EPS ranged from a high of about $0.15 to a steep loss of roughly -$3.35. Over the last 12 months, the company booked about $79.2 million in revenue but remained unprofitable on a trailing basis, setting up a results season where investors are laser focused on whether...

Wondering whether First Advantage is a bargain or a value trap at today’s price? You are not alone. This article walks through what the numbers are really saying about the stock. The share price has slipped 3.7% over the last week, but it is still up 6.9% over the past month and remains well below where it started the year, down 26.7% year to date and 32.1% over the last 12 months, which has many investors reassessing its risk and reward profile. Recent headlines around tighter labor markets...

Citi Trends (CTRN) opened Q3 2026 with revenue of about $197.1 million and a basic EPS of roughly -$0.86, as net income excluding extra items came in around -$6.9 million. This keeps the focus squarely on how quickly the business can tighten its margins. The company has seen quarterly revenue move from $179.1 million in Q3 2025 to $190.8 million in Q2 2026 and then $197.1 million in Q3 2026. Over the same stretch, EPS has swung from -$0.86 to $0.48 and back to -$0.86, underscoring how choppy...

If you are wondering whether CVB Financial is quietly turning into a value opportunity or just a value trap, you are not alone. That is exactly what we are going to unpack here. The stock closed at $19.78, slipping 2.2% over the last week. It is still up 7.7% over the past month, even as it remains down 5.1% year to date and 10.3% over the last year, which hints at shifting market expectations. Recent headlines around regional banks, from changing interest rate expectations to tighter credit...

MaxLinear (MXL) just put a fresh buyback on the table, with its board authorizing up to $75 million in share repurchases funded from existing cash, a move that usually draws close investor attention. See our latest analysis for MaxLinear. The new buyback comes as MaxLinear’s 1 month share price return of 9.5% builds on an 8.9% gain over 3 months, even though its 1 year total shareholder return is still slightly negative, suggesting improving momentum from a depressed base. If this rebound has...